In order to meet the needs of patients at all levels and maintain the leading position of ophthalmology in China, Peking Union Medical College Hospital has specially introduced the world's most advanced full femtosecond device and Amath 750 excimer laser equipment. Since then, all myopia surgery techniques have been used. Can be completed, including corneal surface PRK, LASEK, EPLASIK, TransPRK, LASIK of the stromal layer, ultra-thin LASIK, SBK, LDV, Da Vinci femtosecond LASIK, Zeiss LASIK femtosecond surgery and corneal lens full femtosecond surgery.
In addition, the hospital's ophthalmology department also carried out non-laser height, ultra-high myopia intraocular ICL, TICL surgery, design personalized surgery for patients with refractive errors. The safety, effectiveness and long-term predictability of the surgery are greatly improved. And the operation time is shortened, and more than 80% of the patients on the second day after surgery can work and live normally.
It is worth mentioning that the leading full-laser TransPRK operation can make the patient's postoperative eye reaction mild, and the full femtosecond small incision lens surgery has no corneal incision, both of which guarantee the stability of corneal biomechanics. The perfect treatment for myopia.
It is reported that since 1993, the Department of Ophthalmology of Peking Union Medical College Hospital has first introduced excimer laser corneal myopia surgery in China. Such surgery has developed rapidly in China. More than 1,000 hospitals and centers across the country have carried out corresponding treatments, with an annual operation volume of more than 700,000. Times.
Diclofenac sodium, a non steroidal anti-inflammatory drug, has obvious analgesic, anti-inflammatory and antipyretic effects. The drug has analgesic, anti-inflammatory and antipyretic effects by inhibiting the synthesis of prostaglandins. Therefore, it is one of the typical representative drugs of anti-inflammatory and analgesic drugs. It is often used in the treatment of various mild to moderate acute and chronic pain in orthopedics, such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and so on.
pharmacological action
This product contains diclofenac sodium, which is a non steroidal anti-inflammatory drug. It has obvious analgesic, anti-inflammatory and antipyretic effects. By inhibiting cyclooxygenase and blocking the synthesis of prostaglandins, it has analgesic, anti-inflammatory and antipyretic effects. Its effect is 2 ~ 2.5 times stronger than indomethacin and 26 ~ 50 times stronger than acetylsalicylic acid. It is characterized by strong efficacy, light adverse reactions, small dose and small individual differences.
The binding rate of the drug to plasma protein was 99.7%, and the half-life was 1 ~ 2 hours. The drug was administered according to the recommended dose and interval, and there was no accumulation. The drug is metabolized by the liver, about 60% of the metabolites of the treatment amount are excreted from the kidney, and the excretion of the prototype drug is less than 1%. The rest of the dose is excreted into the intestine in the form of metabolites through bile and removed from feces.
Indications
Relieve rheumatoid arthritis and osteoarthritis. Acute attack or persistent joint swelling and pain symptoms of various chronic arthritis such as spinal arthropathy, gouty arthritis and rheumatoid arthritis. Various soft tissue rheumatic pain, such as shoulder pain, tenosynovitis, bursitis, myalgia and post exercise injury pain. Acute mild and moderate pain, such as pain after operation, trauma and strain, primary dysmenorrhea, toothache, headache, etc.
5% Diclofenac Sodium Injection,Diclofenac Sodium Injection for Cattle,Diclofenac Sodium Injection 5%,Diclofenac Sodium Injection
Shandong Unovet Pharmaceutical Co.,Ltd. , https://www.unovetcn.com